Scholarlink

<p>This study evaluated the phytochemical composition, bioactivity, and safety of purple, yellow, and white <i>Chrysanthemum</i> × <i>morifolium</i> (Ramat.) Hemsl. (<i>C. morifolium</i>) flower extracts using a hydroglycolic solvent blend of water and propylene glycol (PG) in a 1:1 ratio as a solvent for extraction. Quantitative analysis revealed that the purple and yellow flower extracts possessed significantly higher total phenolic content (TPC) and total flavonoid content (TFC) compared to the white flower extract (<i>p</i> &lt; 0.05). These extracts also exhibited superior antioxidant activity, as measured by DPPH and ABTS assays. High-performance liquid chromatography (HPLC) analysis indicated that the purple extract had the highest concentration of luteolin (0.2403% w/w, <i>p</i> &lt; 0.05), while the yellow extract contained the highest levels of chlorogenic acid (0.4320% w/w, <i>p</i> &lt; 0.05) and caffeic acid (0.0289% w/w, <i>p</i> &lt; 0.05). In vitro anti-glycation assays demonstrated that the purple extract exhibited the highest anti-glycation activity (<i>p</i> &lt; 0.05). However, there was no significant difference in anti-collagenase activity between the purple and yellow extracts (<i>p</i> &gt; 0.05). Safety evaluations confirmed that the extracts did not induce skin irritation or sensitization. These preliminary findings suggest the potential of <i>C. morifolium</i> flower extracts, particularly from yellow and purple varieties, as a promising ingredient in plant-based formulations. Initial results indicate antioxidant, anti-glycation, and anti-collagenase properties without apparent adverse skin reactions in vitro. However, further studies, including human clinical trials, are needed to confirm these biological activities and safety profiles.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Phytoconstituent analysis, bioactivity, and safety evaluation of various colors of Chrysanthemum morifolium flower extracts for cosmetic application

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年2月3日

查看全文
  • Angsana Neatpatiparn,
  • Varaporn Buraphacheep Junyaprasert,
  • Krit Thirapanmethee,
  • Veerawat Teeranachaideekul

摘要

This study evaluated the phytochemical composition, bioactivity, and safety of purple, yellow, and white Chrysanthemum × morifolium (Ramat.) Hemsl. (C. morifolium) flower extracts using a hydroglycolic solvent blend of water and propylene glycol (PG) in a 1:1 ratio as a solvent for extraction. Quantitative analysis revealed that the purple and yellow flower extracts possessed significantly higher total phenolic content (TPC) and total flavonoid content (TFC) compared to the white flower extract (p < 0.05). These extracts also exhibited superior antioxidant activity, as measured by DPPH and ABTS assays. High-performance liquid chromatography (HPLC) analysis indicated that the purple extract had the highest concentration of luteolin (0.2403% w/w, p < 0.05), while the yellow extract contained the highest levels of chlorogenic acid (0.4320% w/w, p < 0.05) and caffeic acid (0.0289% w/w, p < 0.05). In vitro anti-glycation assays demonstrated that the purple extract exhibited the highest anti-glycation activity (p < 0.05). However, there was no significant difference in anti-collagenase activity between the purple and yellow extracts (p > 0.05). Safety evaluations confirmed that the extracts did not induce skin irritation or sensitization. These preliminary findings suggest the potential of C. morifolium flower extracts, particularly from yellow and purple varieties, as a promising ingredient in plant-based formulations. Initial results indicate antioxidant, anti-glycation, and anti-collagenase properties without apparent adverse skin reactions in vitro. However, further studies, including human clinical trials, are needed to confirm these biological activities and safety profiles.